Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
2019 pubmed 2 citations

Low KISS1 expression predicts poor prognosis for patients with colorectal cancer: A meta-analysis.

Wang. Xiao-Qing XQ; Fang. Pei-Fei PF; Zhang. Cheng C; Xu. Ya-Yun YY; Song. Xian-Bing XB; Liang. Jun J; Xia. Qing-Rong QR

Key Findings

  • Error

Practical Outcomes

  • Error

Summary

Error: Timeout.

Abstract

KISS1 and KISS1R, a novel pair of metastasis suppressors, are likely to be associated with the prognosis of colorectal cancer (CRC). Here, a meta-analysis was performed to study the role of KISS1 and KISS1R in CRC. Heterogeneity, stability and publication bias were all estimated. Six publications describing a total of 559 CRC patients were included in the present study. Low KISS1 expression predicted 70% higher risk of poor prognosis for general patients (HR, 1.71; 95% CI, 1.28-2.29) and 99% higher risk for East Asian patients (HR, 1.99; 95% CI, 1.46-2.72). Limited evidence indicated that decreased KISS1R expression might predict poor outcome (HR, 2.96; 95% CI, 1.51-5.82). Neither heterogeneity nor publication bias was identified. The current analyses suggest that low KISS1 expression predicts poor overall survival among East Asian patients with CRC. Evidence on other races and KISS1R are still insufficient, and additional studies are required to clarify the risk of CRC associated with KISS1R by race.

Study Information

Provider

pubmed

Year

2019

Date

2019-04-25T00:00:00.000Z

DOI

10.1111/1440-1681.13093

Citations

2

References

36